Akari Therapeutics PLC (NASDAQ:AKTX)

1.35
Delayed Data
As of 4:02pm ET
 -0.075 / -5.26%
Today’s Change
1.31
Today|||52-Week Range
4.21
-10.00%
Year-to-Date
No recent news for Akari Therapeutics PLC.

Today’s Trading

Previous close1.43
Today’s open1.47
Day’s range1.31 - 1.47
Volume19,342
Average volume (3 months)107,513
Market cap$74.2M
Data as of 4:02pm ET, 01/24/2022

Growth & Valuation

Earnings growth (last year)+42.08%
Earnings growth (this year)+100.00%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.86

Competitors

----
----
UBXUNITY Biotechnology ...-0.02-1.67%
ICCCImmuCell Corp+0.42+5.15%
Data as of 4:03pm ET, 01/24/2022

Financials

Next reporting dateMarch 23, 2022
EPS forecast (this quarter)$0.00
Annual revenue (last year)$0.00
Annual profit (last year)-$17.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
London, Greater London

Forecasts